Article
Double hit lymphoma: from biology to therapeutic implications.
Expert review of hematology - 1 Jul 2016
Burotto Mauricio, Berkovits Alejandro, Dunleavy Kieron
Abstract excerpt
INTRODUCTION: Diffuse large B-cell lymphoma (DLBCL) is a molecularly heterogeneous disease defined by different cellular origins and mechanisms of oncogenic activation. Approximately 10% of DLBCL cases harbor a MYC rearrangement and this has been associated with a more aggressive clinical course following standard therapy. AREAS COVERED: So-called 'double-hit lymphomas' (DHL) or 'triple hit lymphomas' (THL) occur...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
